UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Learn when to consider realigning your budget by spotting warning signs such as sinking savings or rising debt. Plan a proactive reset to improve cash flow.
18,979 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
As bond yields wobble, energy stocks secretly better provide income with inflation protection and strong cash flow. E...
A university dean warns that AI's push for efficiency could erase entry-level roles for young workers, even as they d...
MGK's gains have been propelled by a tight core of five megacaps, a dynamic that boosts returns but also raises risk ...
In a higher-rate environment, CDL continues to deliver a reliable monthly cash stream with a $2.29 per-share annual d...
With oil prices near a year high, IEO’s $0.55 quarterly dividend is set to be tested by producer payouts and market s...
Bitcoin remains the market benchmark as XRP pushes deeper into cross-border payments. Analysts weigh XRP's growth aga...
New market outlook examines what 10,000 XRP could worth by 2028, with base, bull, and bear scenarios. Regulatory clar...
A rising share of young Americans talk with neighbors less often, and a new Gallup analysis ties weak neighborhood ti...
Goldman Sachs marks Nvidia and Micron as the leading AI winners ahead of the upcoming earnings season, triggering fre...
A 64-year-old selling a family business in California could see a substantial tax bill after a $3.2 million sale, und...
Stocks surged after reports of a possible U.S. deal with Iran, easing inflation worries and lifting risk assets. Wall...